NCT05399186View on ClinicalTrials.gov

Arthroplasty and Modifiable Risk Factors

NACompletedINTERVENTIONAL
Enrollment

1,484

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Total Joint ArthroplastyRisk ReductionSurgical Site InfectionProsthetic-joint InfectionPostoperative Complications
Interventions
OTHER

Early preoperative assessment and optimization

The interventional group received early preoperative assessment and optimization (6-12 months) prior to total joint arthroplastic surgery in cooperation between hospital and primary care

Trial Locations (1)

108

Landspitali University Hsopital, Reykjavik

All Listed Sponsors
lead

Landspitali University Hospital

OTHER

NCT05399186 - Arthroplasty and Modifiable Risk Factors | Biotech Hunter | Biotech Hunter